OrthoPediatrics’ Management and Board of Directors take its social impact and governance responsibilities very seriously. We believe these areas are central to our business philosophy and ultimately generate increased shareholder value. Our internal team is led by our COO & CFO and reports directly to our Governance Committee.
OrthoPediatrics (the “Company”) continues to drive transformational changes year after year; we have now helped over 1.1 million kids across the globe and our newly established OP Specialty Bracing division (“OPSB”) enables us to enter a new total addressable market which enables us to help even more KIDS every year.
We created our first ever Social Impact and Governance team reporting to Marie Infante, Chair of our Corporate Governance Committee. Ms. Infante also led our Board of Directors’ initiative to increase diversity of our Board by successfully adding several diverse members to our Board, with plans for further action in the future. We continue our industry leading support of surgeon education and are the sole sponsor of a women in pediatric orthopedics mentoring community. We expanded our partnership with the World Pediatric Project, with whom we support medical missions for children in developing countries, thus furthering our commitment to serving KIDS all over the world and being a good neighbor in the communities where we work and live.
Rather than addressing much larger orthopedic markets, we partner with pediatric orthopedic specialists to develop innovative products that facilitate and improve better clinical outcomes for children. We not only make a difference in the lives of these patients, but also their families, who entrust their most precious gift to our surgeon customers and our surgical systems. Since completing our IPO in 2017, we have continued to gain the attention of, and act as a beacon for numerous pediatric start-up companies outside the orthopedic space.
